Brittany A. Lancellotti, DVM, DACVD, gave an overview of the risks and benefits of these systemic medications
While at the Fetch conference in Long Beach, California, Brittany A. Lancellotti, DVM, DACVD, sat down with dvm360 in an interview and explained the risks and benefits of systemic medications used for the treatment of allergic itch and inflammation associated with otitis externa.
The following is a partial transcript of the video.
Brittany A. Lancellotti, DVM, DACVD: Hi I'm Dr Brittany Lancellotti. I am a veterinary dermatologist at Veterinary Skin and Ear in Los Angeles, California.
There are lots of different medications that can be reached for when we are managing otitis externa. And some of the systemic medications that we typically use are going to be focused around the itch and inflammation that triggers the secondary infection...Each of these medications has its own benefits and risks and should be selected based on what that individual pet needs.
